alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
<TABLE> <S> <C>


<ARTICLE>                     5
<LEGEND>
     This schedule  contains summary  financial  information  extracted from the
balance sheet of CNL Income Fund XIII,  Ltd. at June 30, 2000, and its statement
of income for the six months  then ended and is  qualified  in its  entirety  by
reference  to the Form 10-Q of CNL  Income  Fund XIII,  Ltd.  for the six months
ended June 30, 2000.
</LEGEND>

<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                              DEC-31-2000
<PERIOD-START>                                 JAN-01-2000
<PERIOD-END>                                   JUN-30-2000
<CASH>                                         778,550
<SECURITIES>                                   0
<RECEIVABLES>                                  136,648
<ALLOWANCES>                                   43,185
<INVENTORY>                                    0
<CURRENT-ASSETS>                               0<F1>
<PP&E>                                         23,906,858
<DEPRECIATION>                                 2,556,026
<TOTAL-ASSETS>                                 33,876,159
<CURRENT-LIABILITIES>                          0<F1>
<BONDS>                                        0
<PREFERRED-MANDATORY>                          0
<PREFERRED>                                    0
<COMMON>                                       0
<OTHER-SE>                                     32,745,089
<TOTAL-LIABILITY-AND-EQUITY>                   33,876,159
<SALES>                                        0
<TOTAL-REVENUES>                               1,716,780
<CGS>                                          0
<TOTAL-COSTS>                                  422,641
<OTHER-EXPENSES>                               0
<LOSS-PROVISION>                               2,584
<INTEREST-EXPENSE>                             0
<INCOME-PRETAX>                                1,414,533
<INCOME-TAX>                                   0
<INCOME-CONTINUING>                            1,414,533
<DISCONTINUED>                                 0
<EXTRAORDINARY>                                0
<CHANGES>                                      0
<NET-INCOME>                                   1,414,533
<EPS-BASIC>                                  0
<EPS-DILUTED>                                  0
<FN>
<F1> Due to the nature of its  industry,  CNL  Income  Fund  XIII,  Ltd.  has an
unclassified  balance sheet;  therefore,  no values are shown above for currrent
assets and current liabilities.
</FN>


</TABLE>
In the United States Court of Federal Claims

OFFICE OF SPECIAL MASTERS

No. 13-902V 

(Not to be published)

* * * * * * * * * * * * * * * * * * * * * * * * * * * * * 

 * 

PATRICIA K. PATTERSON, * 

 * Filed: June 3, 2015 

 Petitioner, * 

 * Decision by Stipulation; Attorney’s 

 v. * Fees & Costs

 * 

SECRETARY OF HEALTH AND * 

HUMAN SERVICES, * 

 * 

 Respondent. * 

 * 

* * * * * * * * * * * * * * * * * * * * * * * * * * * * * 

Matthew F. Belanger, Rochester, NY, for Petitioner

Linda Renzi, Washington, DC, for Respondent 

ATTORNEY’S FEES AND COSTS DECISION1

On November 13, 2013, Patricia Patterson filed a petition seeking compensation under 

the National Vaccine Injury Compensation Program (Athe Vaccine Program@). On April 6, 2015, 

the parties filed a stipulation detailing an amount to be awarded to Petitioner. I subsequently 

issued a decision finding the parties’ stipulation to be reasonable and granting Petitioner the 

award outlined by the stipulation. 

On June 3, 2015, counsel for both parties filed another joint stipulation, this time in 

regards to attorney’s fees and costs. The parties have stipulated that Petitioner’s counsel should 

receive a lump sum of $45,000.00, in the form of a check payable to Petitioner and Petitioner’s 

1

 Because this decision contains a reasoned explanation for my action in this case, I will post this decision on the 

United States Court of Federal Claims’ website, in accordance with the E-Government Act of 2002, Pub. L. No. 

107-347, § 205, 116 Stat. 2899, 2913 (codified as amended at 44 U.S.C. § 3501 note (2006)). As provided by 42 

U.S.C. § 300aa-12(d)(4)(B), however, the parties may object to the posted decision’s inclusion of certain kinds of 

confidential information. Specifically, under Vaccine Rule 18(b), each party has 14 days within which to request 

redaction “of any information furnished by that party: (1) that is a trade secret or commercial or financial in 

substance and is privileged or confidential; or (2) that includes medical files or similar files, the disclosure of which 

would constitute a clearly unwarranted invasion of privacy.” Vaccine Rule 18(b). Otherwise, the whole decision will 

be available to the public. (Id.) 

 
counsel. This amount represents a sum to which respondent does not object. In addition, and in 

compliance with General Order No. 9, Petitioner has represented that she did incur any 

reimbursable costs in proceeding on this petition. 

I approve the requested amount for attorney’s fees and costs as reasonable. Accordingly, 

an award should be made in the form of a check in the amount of $45,000.00 payable jointly to 

Petitioner and Petitioner’s counsel, Matthew F. Belanger, Esq. In the absence of a motion for 

review filed pursuant to RCFC Appendix B, the clerk of the court SHALL ENTER 

JUDGMENT in accordance with the terms of the parties’ stipulation.2

IT IS SO ORDERED. 

 /s/ Brian H. Corcoran

 Brian H. Corcoran 

 Special Master

2 Pursuant to Vaccine Rule 11(a), the parties may expedite entry of judgment by filing a joint notice renouncing their

right to seek review.
# Exhibit 32.2

# CERTIFICATON OF CHIEF
FINANCIAL OFFICERPursuant to 18 U.S.C. § 1350, as adopted pursuant to
 § 906 of the Sarbanes-Oxley Act of 2002

In connection with the filing with
the Securities and Exchange Commission of the Quarterly Report of Hemagen Diagnostics,
Inc. on Form 10-QSB for the period ending June 30, 2004, the (Report), I,
Deborah F. Ricci, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C.
§ 906 1350, that:

| | (1) | The
Report fully complies with the requirements of Section 13(a) or 15(d) of the
          Securities Exchange Act of 1934; and
| | --- | -------------------------------------------------------------------------------------------------------------------------------

| | (2) | The
information contained in the Report fairly presents, in all material           respects,
the financial condition and results of operations of the Company.
| | --- | --------------------------------------------------------------------------------------------------------------------------------------------------------------

/s/ Deborah F. Ricci

Deborah F. RicciChief Financial Officer(Principal Financial
Officer)

February 14, 2005

A signed original of this written
statement required by Section 906 has been provided to Hemagen Diagnostics, Inc. and will
be retained by Hemagen Diagnostics, Inc. and furnished to the Securities and Exchange
Commission or its staff upon request.

21
SUPREME COURT OF THE STATE OF NEW YORK

Appellate Division, Fourth Judicial Department

988 

TP 11-00646 

PRESENT: SMITH, J.P., CENTRA, CARNI, AND LINDLEY, JJ.

 

 

IN THE MATTER OF NEW YORK STATE DIVISION OF 

HUMAN RIGHTS AND GENISE BENSON, PETITIONERS,

V MEMORANDUM AND ORDER

NANCY POTENZA DESIGN & BUILDING SERVICES, INC., 

ROCCO POTENZA, INDIVIDUALLY, HEALTHNOW NEW 

YORK, INC., DOING BUSINESS AS BLUECROSS BLUESHIELD 

OF WESTERN NEW YORK, POTENZA SERVICES INC., AS 

SUCCESSOR-IN-INTEREST, AND POTENZA SERVICE, INC., 

AS SUCCESSOR-IN-INTEREST, RESPONDENTS. 

 

CAROLINE J. DOWNEY, BRONX (TONI ANN HOLLIFIELD OF COUNSEL), FOR

PETITIONERS. 

 

Proceeding pursuant to Executive Law § 298 (transferred to the

Appellate Division of the Supreme Court in the Fourth Judicial

Department by order of the Supreme Court, Erie County [Joseph R.

Glownia, J.], entered January 4, 2011) to enforce a determination of

the New York State Division of Human Rights. 

It is hereby ORDERED that the determination is unanimously

confirmed without costs and the petition is granted.

Memorandum: Petitioner New York State Division of Human Rights

(SDHR) commenced this proceeding for judicial review and enforcement

of an order pursuant to Executive Law § 298 finding that respondent

Nancy Potenza Design & Building Services, Inc. was liable, as the

complainant’s employer, of aiding and abetting the sexual harassment

of the complainant. The Administrative Law Judge (ALJ) awarded the

complainant $10,000 in compensatory damages based on a hostile work

environment claim and the Commissioner of SDHR (Commissioner) adopted

the recommended order of the ALJ. We conclude that there is

substantial evidence supporting the determination (see generally 300

Gramatan Ave. Assoc. v State Div. of Human Rights, 45 NY2d 176, 181-

182). 

The fact that the sexual harassment did not take place on the

employer’s premises does not relieve the employer of liability under

the Human Rights Law (Executive Law art 15; see Lockard v Pizza Hut,

162 F3d 1062). Additionally, respondent Rocco Potenza, as the owner

and president of the employer who condoned the sexual harassment, may

be held individually liable for the discriminatory actions that

damaged the complainant (see Patrowich v Chemical Bank, 63 NY2d 541,
-2- 988 

TP 11-00646 

542). Finally, we conclude that the amount of the award is reasonably

related to the wrongdoing and is supported by the evidence before the

Commissioner (see Matter of New York State Dept. of Correctional

Servs. v New York State Div. of Human Rights, 265 AD2d 809).

Entered: September 30, 2011 Patricia L. Morgan

Clerk of the Court
EXHIBIT 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

WRITTEN STATEMENT OF THE CHIEF EXECUTIVE OFFICER

Solely for the purposes of complying with 18 U.S.C. §1350, as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002, I, Warren D. Stowell, the undersigned Chief Executive Officer of Telzuit Medical Technologies, Inc. (the
Company), hereby certify, based on my knowledge, that the Annual Report on Form 10-KSB of the Company for the year ended June 30, 2006 (the Report) as filed with the Securities and Exchange Commission on the date hereof:



|1. | Fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
|-- | ----------------------------------------------------------------------------------------------------------



|2. | That the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
|-- | ---------------------------------------------------------------------------------------------------------------------------------------------------------



/s/ Warren StowellWarren D. StowellPresident and Chief Executive OfficerNovember 1, 2006
FILED

United States Court of Appeals

Tenth Circuit

June 28, 2010

Elisabeth A. Shumaker

Clerk of Court

UNITED STATES COURT OF APPEALS

FOR THE TENTH CIRCUIT

HASKELL BRUCE LEE, SR., 

 Petitioner - Appellant,

v.

STATE OF OKLAHOMA, 

 Respondent - Appellee. 

No. 10-5071

(D.C. No. 4:10-CV-00044-TCK-PJC) 

ORDER

Appellant’s motion to dismiss this matter is granted. 10th Cir. R. 27.3(A)(9).

A copy of this order shall stand as and for the mandate of the court.

Entered for the Court,

ELISABETH A. SHUMAKER, Clerk

Appellate Case: 10-5071 Document: 01018448750 Date Filed: 06/28/2010 Page: 1
DAVID L. COLLIER

,

Petitioner,

v.

JULIE L. JONES, SECRETARY,
FLORIDA DEPARTMENT OF
CORRECTIONS

,

Respondent.

___________________________/ IN THE DISTRICT COURT OF APPEAL FIRST DISTRICT, STATE OF FLORIDA

NOT FINAL UNTIL TIME EXPIRES TO
FILE MOTION FOR REHEARING AND
DISPOSITION THEREOF IF FILED

CASE NO. 1D 14

- 5174

Opinion filed May 22, 2015.

Petition for Writ of Certiorari

-- Original Jurisdiction

.

David L. Collier, pro se

, Petitioner.

Pamela Jo Bondi, Attorney General, and Holly N. Simcox, Assistant Attorney General, Tallahassee , for Respondent.

PER CURIAM.

This case is duplicative of the proceedings in case number 1D14

- 0817.

Accordingly, the instant petition is hereby DISMISSED. Montgomery v. Crosby , 889

So. 2d 998 (Fla. 1st DCA 2 004).

THOMAS, MARSTILLER, and BILBREY, JJ., CONCUR.
Exhibit 12.1

CERTIFICATIONS

I, Takeshi Uchiyamada, certify that:



| | 1. | I have reviewed this annual report on Form 20-F/A of Toyota Motor Corporation (the Company); and
| | -- | --------------------------------------------------------------------------------------------------



| | 2. | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the
statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report.
| | -- | ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Date: October 23, 2017



|                                                     
|-----------------------------------------------------
|/s/    TAKESHI UCHIYAMADA                            
|Takeshi Uchiyamada Chairman of the Board of Directors
|Toyota Motor Corporation                             



---

CERTIFICATIONS

I, Osamu Nagata, certify that:



| | 1. | I have reviewed this annual report on Form 20-F/A of Toyota Motor Corporation (the Company); and
| | -- | --------------------------------------------------------------------------------------------------



| | 2. | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the
statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report.
| | -- | ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Date: October 23, 2017



|                                  
|----------------------------------
|/s/    OSAMU
NAGATA               
|Osamu Nagata                      
|Executive Vice President, Director
<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE AUDITED
FINANCIAL STATEMENTS OF PHON-NET.COM, INC. FOR THE YEAR ENDED JULY 31, 2000 AND
IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH REPORT.
</LEGEND>

<S>                             <C>
<PERIOD-TYPE>                   12-MOS
<FISCAL-YEAR-END>                          JUL-31-2000
<PERIOD-START>                             AUG-01-1999
<PERIOD-END>                               JUL-31-2000
<CASH>                                         154,481
<SECURITIES>                                         0
<RECEIVABLES>                                  205,550
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                               358,971
<PP&E>                                       1,380,078
<DEPRECIATION>                                (654,703)
<TOTAL-ASSETS>                               1,084,346
<CURRENT-LIABILITIES>                          190,513
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                    12,474,514
<OTHER-SE>                                 (11,580,681)
<TOTAL-LIABILITY-AND-EQUITY>                10,843,346
<SALES>                                          6,896
<TOTAL-REVENUES>                                 6,896
<CGS>                                                0
<TOTAL-COSTS>                                        0
<OTHER-EXPENSES>                             4,547,738
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                                      0
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                                  0
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                (4,540,842)
<EPS-BASIC>                                      (0.12)
<EPS-DILUTED>                                    (0.00)


</TABLE>
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the  discussions could disclose confidential trade secrets or commercial property such as patentable  material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

*Name of Committee:*                         Heart, Lung, and Blood Initial Review Group, Heart, Lung, and Blood Program Project Review Committee.                    

*Date:*                         December 1, 2010.                    

*Time:*                         8 a.m. to 5 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         Hyatt Regency Bethesda, One Bethesda Metro Center, 7400 Wisconsin Avenue, Bethesda, MD 20814.                    

*Contact Person:*                         Jeffrey H Hurst, PhD, Scientific Review Officer, Review Branch/DERA, National Heart, Lung, and Blood Institute, 6701 Rockledge Drive, Room 7208, Bethesda, MD 20892-7924, 301-435-0303,                          *hurstj@nhlbi.nih.gov.*

(Catalogue of Federal Domestic Assistance Program Nos. 93.233, National Center for Sleep  Disorders Research; 93.837, Heart and Vascular Diseases Research; 93.838, Lung Diseases  Research; 93.839, Blood Diseases and Resources Research, National Institutes of Health, HHS)

Dated: November 1, 2010.

Jennifer S. Spaeth,

Director, Office of Federal Advisory Committee Policy.

[FR Doc. 2010-28069 Filed 11-4-10; 8:45 am]

BILLING CODE 4140-01-P
****Exhibit 10.2**

Director Fee Arrangements for 2005**

 
         Each director of *MutualFirst* Financial, Inc.(the "Company") also is a director of Mutual Federal Savings Bank (the "Bank").For 2005, as for 2004, each non-employee director receives an annual fee of$25,200 for serving on the Bank's Board of Directors. In addition to this annualfee, Wilbur R. Davis receives a $5,000 annual fee for serving as Chairman of theBoard of Directors of the Bank. Directors are not compensated for their serviceon the Company's Board of Directors.

         The Bank maintains deferred compensation arrangements with some directorswhich allows them to defer all or a portion of their Board fees and receiveincome when they are no longer active directors. Deferred amounts earn interestat the rate of 10 percent per year.
#### Jarmin Wilson, Appellant, v Sherman Terrace Cooperative, Inc., Respondent.

[787 NYS2d 318]

*368Order, Supreme Court, Bronx County (Barry Salman, J.), entered on or about March 22, 2004, which, in an action for personal injuries sustained when plaintiff tripped and fell on the sidewalk, used as a driveway, in front of defendant’s multiple dwelling, after a hearing, granted defendant’s motion to vacate its default in answering the complaint, unanimously affirmed, without costs.

Defendant showed a reasonable excuse for its default, namely, that its former superintendent, who had been served with the summons and complaint, was unaware of their importance and mislaid them among his other papers, and that defendant did not discover them until after the superintendent had been discharged *(cf. Goldman v*Cotter, 10 AD3d 289, 291 [2004]; *Chase Manhattan Auto. Fin. Corp. v Allstate Ins. Co.,*272 AD2d 772, 774 [2000]). Plaintiffs claim that service was also made on a second person who appeared to be a supervisor in the office of defendant’s management company lacks support in the record *(see Warney v Haddad,*194 AD2d 478 [1993], *lv denied*82 NY2d 658 [1993]). A meritorious defense was shown by the affidavit of defendant’s board member, also a resident of the building, that he never saw any defects in the sidewalk or driveway in front of the building *(see Galbreith v Torres,*9 AD3d 304 [2004]). Concur—Buckley, P.J., Sullivan, Nardelli, Williams and Sweeny, JJ.
EXHIBIT  32.1  &  32.2

      STATEMENT REQUIRED BY 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In  connection  with  the  Annual  Report on Form 10-KSB of Senticore, Inc. (the
"Company")  for  the  year ended December 31, 2003, as filed with the Securities
and  Exchange  Commission on the date hereof (the "Report"), I, Jay Patel, Chief
Executive  Officer,  and Carl Gessner, President, Secretary, Treasurer and Chief
Financial  Officer  of  the  Company,  certify  that:

*    the  Report  fully complies with the requirements of Section 13(a) or 15(d)
     of  the  Securities  Exchange  Act  of  1934;  and

*    information  contained  in  the  Report  fairly  presents,  in all material
     respects, the financial condition and results of operations of the Company.



/s/  Jay  Patel
---------------
Jay  Patel
Chief  Executive  Officer

April  19,  2004



/s/  Carl  Gessner
------------------
Carl  Gessner
President,  Secretary,  Treasurer  and  Chief  Financial  Officer

April  19,  2004

This  certification  accompanies  this  Report  pursuant  to  Section 906 of the
Sarbanes-Oxley  Act  of 2002 and shall not, except to the extent required by the
Sarbanes-Oxley  Act  of  2002,  be  deemed  filed by the Company for purposes of
Section  18  of  the  Securities  Exchange  Act  of  1934,  as  amended.